Researchers today received more than $14 million in grants to develop DNA sequencing technologies that will rapidly sequence a person’s genome for $1000 or less. The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, awarded the grants to enable the everyday use of DNA sequencing technologies by biomedical researchers and health care providers.
Related posts:
- Researchers complete whole-exome sequencing of skin cancer A team led by researchers at the National Institutes of Health is the first to systematically survey the landscape of the melanoma genome, the DNA code of the deadliest form of skin cancer. The researchers have made surprising new discoveries using whole-exome sequencing, an approach that decodes the 1-2 percent of the genome that contains […]...
- eMERGE network moves closer to tailored treatments based on patients’ genomic information Researchers in the Electronic Medical Records and Genomics (eMERGE) network will receive $25 million over the next four years to demonstrate that patients’ genomic information linked to disease characteristics and symptoms in their electronic medical records can be used to improve their care. The grants are from the National Human Genome Research Institute (NHGRI), part […]...
- Medicare, NHGRI charts course for the next phase of genomics research Medicare, NHGRI charts course for the next phase of genomics research...
- Discovered gene causes Kabuki syndrome Using a new, rapid and less expensive DNA sequencing strategy, scientists have discovered genetic alterations that account for most cases of Kabuki syndrome, a rare disorder that causes multiple birth defects and mental retardation. Instead of sequencing the entire human genome, the new approach sequences just the exome, the 1-2 percent of the human genome […]...
- Medicare, NIH researchers identify genetic elements influencing the risk of type 2 diabetes Medicare, NIH researchers identify genetic elements influencing the risk of type 2 diabetes: A team led by researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, has captured the most comprehensive snapshot to date of DNA regions that regulate genes in human pancreatic islet cells, a subset of […]...
- Researchers identify gene variant in Proteus syndrome A team of researchers has identified the genetic mutation that causes Proteus syndrome, a rare disorder in which tissue and bone grows massively out of proportion. The discovery, which has implications for potential drug therapies and even cancer, appears in the July 27, 2011, early online edition of the New England Journal of Medicine. The […]...
- Medicare Card News: NIH Researchers Explore How Healthy, Young Adults View the Role Genetics Plays in Improving Health Most healthy young adults place greater emphasis on health habits than on genetic risk factors when considering what causes common diseases, a research team from the National Human Genome Research Institute (NHGRI) and the Henry Ford Health System in Detroit has found. The study, based on a survey of 25- to-45-year-olds, was released June 8, […]...
- Medicare: FCC Honors Innovators of Accessible Communications Technologies The Federal Communications Commission (FCC) presented the Chairman’s Awards for Advancement in Accessibility (AAA) to several organizations that have made important technological innovations to help people with disabilities benefit from communications technologies. The awards ceremony was held in conjunction with National Disability Employment Awareness Month and the one year anniversary of the 21st Century Communications […]...
- Areas Get Millions in Recovery Act Funds The National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health...
- Medicare Card, Scientists Identify Markers, Human Breast Cancer Cells, Linked to Development of an Aggressive, But Less Common Form of Breast Cancer Scientists have identified a group of surface markers on cells linked to an aggressive type of breast cancer called estrogen receptor-negative cancer. In this preliminary study, estrogen-negative breast cancer developed when three markers, CD44+, CD49fhi, and CD133hi were present simultaneously on the surface of human cells taken from breast cancer patients and transplanted into a […]...
- NIEHS Awards Recovery Act Funds Focus More Research on Health and Safety of Nanomaterials NIEHS Awards Recovery Act Funds to Focus More Research on Health and Safety of Nanomaterials ...
- Medicare Card, National Institutes of Health launches summer institute on mHealth The National Institutes of Health today announced the creation of the first NIH Health, or mobile health, Summer Institute. Scheduled for the summer of 2011, this week-long workshop will bring together leaders in mobile health technologies, behavioral science researchers, federal health officials and members of the medical community to provide early career investigators with an […]...
- Medicare Card, NIH Funds 10 International Centers of Excellence for Malaria Research In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world....
- NIBIB and the Indian Department of Biotechnology Collaborate to Develop Low-Cost Medical Devices The National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, announced the availability of supplemental funding for eligible NIBIB-supported research grants to facilitate collaborative work among researchers in the United States and India....
- NIDA Avant-Garde-Medications Development Award winners announced Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA’s second Avant-Garde Awards for Innovative Medication Development Research. The two scientists, Dr. Thomas Kosten, of Baylor College of Medicine, Houston, and Dr. Peter Burkhard, of the University of Connecticut, Storrs, will each receive $500,000 per year for five years to […]...